AGL Energy Ltd powers up with $1.5 billion Macquarie Generation acquisition

After last week's statement by the ACCC some investors will be surprised by the acquisition agreement.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The wait is over for investors wondering if AGL Energy Ltd (ASX: AGK) or ERM Power Ltd (ASX: EPW) would be successful in their bids for the electricity generation business owned by the NSW government Macquarie Generation (Macgen).

While there is still one major hoop to jump through – gaining approval from the Australian Competition and Consumer Commission (ACCC) – this morning it has been announced that AGL has entered into an agreement to acquire Macgen for $1.505 billion.

Last week the ACCC issued a statement outlining concerns regarding the proposed acquisition of Macgen by AGL and stated that its "preliminary view is that the proposed acquisition is likely to result in a substantial lessening of competition in the market for the retail supply of electricity in NSW as a result of reduced access to competitively priced and customised hedge contracts."

The ACCC also noted that if the acquisition was to proceed, AGL, Origin Energy Limited (ASX: ORG) and Energy Australia would have between 70% and 80% of the electricity generation capacity in NSW and over 85% of the retail market in NSW between them.

The tone of the ACCC's statement certainly wouldn't have filled either AGL or the NSW Government with confidence that the ACCC will ultimately grant approval – a final decision is due to be released on 4 March – presumably AGL had the winning bid (it has entered into an agreement with Macgen) so both parties are pursuing the acquisition and will await the ACCC's decision.

Importantly for shareholders, assuming the ACCC grants approval for the acquisition, then AGL plans to undertake a fully underwritten renounceable rights issue to raise approximately $1.2 billion with the balance of the acquisition costs to be funded with $350 million of bank debt.

Foolish takeaway

While AGL will gain from the acquisition of Macgen, arguably of greater consequence is that ERM loses. The acquisition of Macgen by ERM would have been transformational for the up-and-coming energy generator and retailer.

Motley Fool contributor Tim McArthur owns shares in Origin Energy Ltd.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »